Click on a filter below to refine your search. Remove a filter to broaden your search.
nalysis included 814,987 men (aged 40 to 99 years) with prostate cancer followed up for up to 10 years through cancer registries in eight US states.
Researchers devised a new way to ensure that older adults aren’t being overtreated or tested needlessly via unnecessary screenings.
A pooled analysis of four large-scale trials demonstrated the sustained effect on colorectal cancer incidence and mortality for 15 years.
Almost 20 million new cases of cancer were reported in 2022, plus 9.7 million deaths from cancer.
A small but significant reduction was seen in prostate cancer deaths, but no reduction was seen in all-cause mortality.
Reductions seen in death from a variety of causes; PHDI scores were also associated with environmental impact
The prostate cancer incidence increased from 2014 to 2019; there was a large decrease in cervical cancer incidence linked to the HPV vaccine.
For those with high cardiovascular health level, no significant difference was seen in disease-free life expectancy based on socioeconomic status.
The leading contributors to the widening gender life expectancy gap from 2019 to 2021 included COVID-19 and unintentional injuries.
Greater adherence to four healthy eating patterns was linked to a lower risk for total and cause-specific mortality.